Cannie IL-5 nucleic acid molecules
US7183080B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Feb 24, 2004 |
| Grant date | Feb 27, 2007 |
| Priority date | — |
| Expiry date | Feb 24, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2799/021
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to canine interleukin-5 proteins; canine interleukin-5 nucleic acid molecules, including those that encode canine interleukin-5 proteins; to antibodies raised against such proteins; and to inhibitory compounds that regulate such proteins. The present invention also includes methods to identify and obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. Also included in the present invention are therapeutic compositions comprising such proteins, nucleic acid molecules, antibodies and/or inhibitory compounds as well as the use of such therapeutic compositions to regulate an immune response in an animal.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.